Private Prescription Costs: Skip the NHS Queue
Private vs NHS Route: Mounjaro vs Wegovy Cost Analysis
When comparing Mounjaro vs Wegovy cost through private prescription in the UK, the primary advantage lies in circumventing NHS restrictions entirely. The NHS route requires GP referral to specialist weight management services, often involving 6-month waiting lists and strict eligibility criteria including failed conventional weight loss attempts. Private prescription eliminates these barriers, offering direct access to either prescription-only medicine through clinical assessment.
Both Wegovy (semaglutide) and Mounjaro (tirzepatide) represent significant monthly investments, but private treatment provides immediate access to the same genuine medications dispensed through NHS channels. EverydayMeds operates under GPhC registration #9012878, ensuring identical pharmaceutical standards while offering transparent Mounjaro vs Wegovy cost comparisons. The convenience factor often justifies the private route for patients frustrated with NHS delays.
Wegovy Pricing Structure: Complete Mounjaro vs Wegovy Cost Breakdown
Understanding Wegovy's dose escalation helps clarify the true Mounjaro vs Wegovy cost comparison over time. Wegovy starts at £79.99 for the 0.25mg starter dose (weeks 1-4), progressing to £94.99 for 0.5mg (weeks 5-8), £99.99 for 1mg (weeks 9-12), £139.99 for 1.7mg (weeks 13-16), and finally £209.99 for the 2.4mg maintenance dose. These prices reflect final costs after applying discount codes FIRST40 for new customers or DOSE25 for returning patients.
Bundle options provide treatment continuity without multiple orders, such as our Intro Trio (0.25mg, 0.5mg, 1mg) at £299.99 covering the first three months, or the Ultimate Stability Trio offering three months of maintenance 2.4mg doses for £649.99. When evaluating Mounjaro vs Wegovy cost considerations, Wegovy's predictable pricing structure allows accurate long-term budgeting compared to Mounjaro's varying dose requirements.
Clinical Evidence: Mounjaro vs Wegovy Cost-Effectiveness
Clinical trials demonstrate both medications' efficacy when prescribed alongside diet and exercise modifications. The STEP trials showed patients taking Wegovy achieved approximately 15% average weight loss at 68 weeks, while Mounjaro's SURMOUNT studies indicated similar effectiveness with its dual GIP and GLP-1 receptor mechanism. When considering Mounjaro vs Wegovy cost implications, both represent evidence-based investments in clinically-proven weight management support.
The landmark SELECT trial published by Wilding et al. in NEJM 2021 demonstrated Wegovy's cardiovascular benefits, showing 20% reduction in major cardiovascular events. This additional health outcome may influence individual Mounjaro vs Wegovy cost-benefit calculations, particularly for patients with existing cardiovascular risk factors requiring comprehensive weight management intervention.
How Wegovy Works: Understanding Your Investment
Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics natural fullness hormones produced in your intestines after eating. This prescription-only medicine works directly on brain appetite centres, reducing hunger signals and promoting earlier satiety during meals. The mechanism may help reduce food cravings and portion sizes naturally, supporting sustainable eating pattern changes. Unlike rapid-acting appetite suppressants, Wegovy provides consistent appetite regulation throughout the week with once-weekly injections. Understanding this mechanism helps justify the Mounjaro vs Wegovy cost considerations, as you're investing in sustained biological appetite support rather than temporary hunger suppression.
Ordering Process: Streamlined Private Prescription Access
EverydayMeds simplifies the Mounjaro vs Wegovy cost comparison through our streamlined ordering process designed for busy lifestyles. Complete our 3-minute clinical assessment covering medical history, current medications, and weight management goals without scheduling GP appointments or specialist consultations. Our qualified prescribers review applications within standard 3 working days, or 24 hours with express service for urgent treatment needs. Once approved, both Wegovy and Mounjaro ship via next-day cold-chain delivery, maintaining pharmaceutical integrity from our GPhC-registered facility (#9012878) directly to your door. This efficient process eliminates traditional prescription delays while ensuring proper clinical oversight for either prescription-only medicine option.
Storage and Practical Considerations in Mounjaro vs Wegovy Cost
Wegovy offers superior storage flexibility compared to Mounjaro, remaining stable at room temperature below 30°C for up to 6 weeks versus Mounjaro's 21-day limit. This storage advantage reduces medication waste if you travel frequently or experience fridge malfunctions, potentially impacting long-term Mounjaro vs Wegovy cost calculations. Both medications require refrigeration at 2-8°C before first use and utilize pre-filled FlexTouch pen injectors for convenient weekly self-administration. The dose escalation schedule prevents starting at maintenance doses immediately, requiring gradual progression through increasing strengths over 16 weeks. Understanding these practical factors helps inform realistic Mounjaro vs Wegovy cost budgeting for successful long-term treatment commitment.
Private Prescription Advantages: Why UK Patients Choose EverydayMeds
The Mounjaro vs Wegovy cost comparison becomes more favourable through private prescription when factoring time-value benefits and treatment accessibility. NHS specialist referrals often require documented evidence of failed diet attempts, BMI measurements, and comorbidity assessments before approving either medication. Private prescription bypasses these administrative requirements, offering immediate access based on clinical assessment alone.
EverydayMeds provides identical pharmaceutical products to NHS dispensaries but with enhanced service levels including weekend processing, express prescriber reviews, and dedicated patient support. Our transparent pricing model eliminates surprise costs, while discount codes reduce initial treatment barriers for new patients exploring either medication option.
Making Your Choice: Expert Support for Treatment Selection
Both Wegovy and Mounjaro are available from EverydayMeds, and your prescriber can help determine which medication aligns with your specific health profile and budget considerations. Our clinical team evaluates individual medical histories, concurrent medications, and treatment preferences to recommend the most appropriate option. The Mounjaro vs Wegovy cost difference may influence some decisions, but efficacy and tolerability remain primary selection criteria. Whether you choose Wegovy's proven GLP-1 pathway or Mounjaro's innovative dual-receptor approach, both represent significant investments in evidence-based weight management support. Apply discount code FIRST40 for new patient savings, or DOSE25 for returning customers, and begin your privately-prescribed weight management journey today through https://everydaymeds.co.uk/collections/wegovy.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
